James Lok

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Protein Protein

Hepatitis B Virus

Randomized Controlled Trial

Top Venues

Alimentary pharmacology & therapeutics

Frontline gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

James Lok
Editorial: Trajectory of soluble programmed cell death protein-1 and ligand-1 in HBV-infected individuals treated with pegylated interferon-implications for stopping rules and the HBV cure programme. Alimentary pharmacology & therapeutics (2024)
James Lok
Editorial: Trajectory of soluble programmed cell death protein-1 and ligand-1 in HBV-infected individuals treated with pegylated interferon-implications for stopping rules and the HBV cure programme. Alimentary pharmacology & therapeutics 60 (5) (2024)
James Lok, Geoffrey Dusheiko, Ivana Carey, Kosh Agarwal
Review article: novel biomarkers in hepatitis B infection. Alimentary pharmacology & therapeutics 56 (5) (2022)
James Lok, Kosh Agarwal
Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update. Viruses 13 (7) (2021)
James Lok, Markus Gess
Liver dysfunction in COVID-19: a useful prognostic marker of severe disease? Frontline gastroenterology 12 (4) (2020)